Letteratura scientifica selezionata sul tema "Cancer de poumon"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Cancer de poumon".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Cancer de poumon"
Chaleat, S., e L. Greillier. "Cancer du poumon". Revue des Maladies Respiratoires Actualités 11 (ottobre 2019): S29—S35. http://dx.doi.org/10.1016/s1877-1203(19)30161-2.
Testo completoBoucly, A., e B. Milleron. "Dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 6, n. 2 (maggio 2014): 115–17. http://dx.doi.org/10.1016/s1877-1203(14)70525-7.
Testo completoAntoni, D., e F. Mornex. "Cancer du poumon : « Les » radiothérapies". Revue des Maladies Respiratoires Actualités 8, n. 5 (settembre 2016): 332–40. http://dx.doi.org/10.1016/s1877-1203(16)30122-7.
Testo completoToffart, A. C., M. Giaj Levra, L. Ferrer, J. Pinsolle, N. Terzi e D. Moro-Sibilot. "Réanimation et cancer du poumon". Revue des Maladies Respiratoires Actualités 10, n. 3 (ottobre 2018): 262–68. http://dx.doi.org/10.1016/s1877-1203(18)30019-3.
Testo completoRochon, Madeleine. "Tabagisme et cancer du poumon". Gérontologie et société 26 / n° 105, n. 2 (2003): 69. http://dx.doi.org/10.3917/gs.105.0069.
Testo completoLüthi, François, Christian Monnerat, Roger Stupp, Hans-Beat Ris, Abderrrahim Zouhair e Thomas McKee. "Cancer du poumon : portrait 2004". Revue Médicale Suisse 62, n. 2477 (2004): 776–82. http://dx.doi.org/10.53738/revmed.2004.62.2477.0776.
Testo completoMilleron, B., S. Couraud, E. Grolleau e V. Gounant. "Le dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 14, n. 2 (ottobre 2022): 2S37–2S41. http://dx.doi.org/10.1016/s1877-1203(22)00098-2.
Testo completoGrolleau, E., M. Darrason, J. de Bermont, B. Milleron e S. Couraud. "Le dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 13, n. 2 (settembre 2021): 2S21–2S25. http://dx.doi.org/10.1016/s1877-1203(21)00092-6.
Testo completoMilleron, B., V. Gounant, A. Khalil e S. Couraud. "Le dépistage du cancer du poumon". Revue de Pneumologie Clinique 73, n. 1 (febbraio 2017): 27–33. http://dx.doi.org/10.1016/j.pneumo.2016.10.002.
Testo completoPerez, Noemí Busquets, Berta Bernad, Javier Narváez e José Valverde. "Érythème noueux et cancer du poumon". Revue du Rhumatisme 73, n. 5 (maggio 2006): 525–26. http://dx.doi.org/10.1016/j.rhum.2005.06.011.
Testo completoTesi sul tema "Cancer de poumon"
Meary, Alexandre. "Schizophrenie et cancer du poumon". Paris 6, 2001. http://www.theses.fr/2001PA062055.
Testo completoBenizri, Emmanuel. "HIF-1alpha : le poumon du cancer". Nice, 2007. http://www.theses.fr/2007NICE4044.
Testo completoAny alive organism can survive without energy, which involves a satisfactory oxygen and nutriments supply. At the initial phase of tumor progression, cells proliferate without their own vascularization ; indeed, oxygen and nutrients are delivered by simple diffusion. Nevertheless, beyond a certain size, these mechanisms are no more effective and oxygen deficiencies appear. The transcription factor HIF (Hypoxia Inducible Factor) is a key regulator required to maintain oxygen homeostasis. HIF is composed of a constitutive HIF-â sub-unit and a HIF- 1á sub-unit, specific of the hypoxic cascade. Three hifá genes have been identified : hif1a, epas 1 and hif3a that code for HIF-1á, HIF-2á and HIF-3á, respectively. Because of its ubiquitous tissue distribution and its central impact on the regulation of the target genes, HIF- 1á is the mosty studied isoform. During my laboratory training, I have contributed to 3 main projects : • First, I have been focused on the regulatory mechanisms that control HIF-1á stability and more precisely, on the study of the HIF prolyl-hydroxylase (PHDs). Using a RNA interference (RNAi) approach, we have highlighted PHD2 as the key isoform that controls HIF-1á stability in normoxia. Related to clinical studies, we have evaluated the impact of HIF-1á immunostaining in a serie of breast cancer. We have shown that HIF-1á is an independent prognostic factor and a bad preditive factor for classical adjuvant treatments. • Finally, in a pre-clinical study, we have analyzed the impact of HIF-1á invalidation by RNAi in a xenograft melanoma model. We have reported a reduction of tumor growth in mice treated with siRNAs targeting HIF-1á
Michel, Noémie. "Analyse de la contribution des kallicréines tissulaires 6 et 12 à la physiopathologie pulmonaire". Thesis, Tours, 2013. http://www.theses.fr/2013TOUR3303/document.
Testo completoRecently, human tissue kallikreins (KLK) emerged as a new family of serine proteases which might play a major role in the tumorigenesis. The project aims at determining the contribution of KLK6 and 12 in lung pathophysiology. We showed that ectopic KLK6 promoted A549 cell proliferation in a protease activity-dependant manner, inhibited cell apoptosis and induced β-catenin nuclear translocation. Furthermore, this study uncovered a signaling pathway mediated by KLK6 in promoting A549 cell proliferation trough activation of the PAR2-EGFR-ERK pathway.We have also identified novel substrates of KLK12, the CCN family. We reported that KLK12-mediated proteolysis of CCN1 and CCN5 can reduce or abolish the binding of VEGF, BMP2, and TGF-β1
Pardo, Olivier. "Thérapie génique du cancer du poumon par la HSP65". Paris 5, 1997. http://www.theses.fr/1997PA05P120.
Testo completoDerniame, Sophie. "Cancer du poumon / Réponse immunitaire locale - modulation tumeur dépendante". Nancy 1, 2006. http://docnum.univ-lorraine.fr/public/SCD_T_2006_0097_DERNIAME.pdf.
Testo completoLung cancer is the most frequent type of cancer in the world. Smoking is clearly the major cause of this pathology. The proliferation of tumor cells induces an inflammatory stromal reaction comprising numerous tumor-infiltrating lymphocytes. In this study, four complementary approaches have been used to study the tumor-dependent modulation of the immune system : TCR Vβ repertoire usage in flow cytometry, TCRγ gene clonal rearrangements in denaturing gradient gel electrophoresis (DGGE/TTGE), tumor and healthy lung tissue infiltration as well as lymph nodes characteristics in immunohistology and cytokine production by RNA RT-PCR. The results obtained have demonstrated the oligoclonality of T-cells in the three types of tissues tested. A Vβ13. 1 clone and a gamma clone appeared to be specifics of epidermoid carcinoma. Similarly, two TCRγ clones appeared to be restricted to adenocarcinoma. Moreover, the CD3/TCR complex was clearly down regulated in tumors compared to healthy tissue or lymph nodes. Similarly, HLA-DR, HLA-DQ and β2 microglobuline, strongly expressed on healthy pneumocytes were nearly absent from tumor cells. Several cytokines with antagonistic effects were detected within tumoral tissue, especially TGFβ and IL-10, which favour tumor growth and TNFalpha and IFNγ which potentialize the anti-tumoral immune response. In conclusion, the clones identified in healthy lung tissue could be specific of early pre-tumoral lesions induced by tobacco smoke, and some of the clones appear to be tumor-specific. However, the immune system has been defeated by several mechanisms, including a decrease of the expression of partners of the immunological synapse and the production of antagonistic cytokines
CAILLET, BRUNO. "Genetique et cancer du poumon : interet des etudes familiales". Lyon 1, 1991. http://www.theses.fr/1991LYO1M273.
Testo completoSève, Pascal. "Pharmacorésistance et cancer du poumon Non à petites cellules". Lyon 1, 2006. http://www.theses.fr/2006LYO10008.
Testo completoCauchi, Stéphane. "Etude des polymorphismes génétiques du récepteur aux hydrocarbures polycycliques aromatiques (AHR) et de son répresseur (AHRR) : relation avec l'inductibilité du CYP1A1 et le cancer pulmonaire". Paris 5, 2003. http://www.theses.fr/2003PA05N030.
Testo completoPolycyclic aromatic hydrocarbons (PAH) found in cigarette smoke play a key role in the appearance of the lung cancer at the smokers. Cytochrome P-4501A1, metabolizes these HPA like benzo(a)pyrene in reactive and mutagen compounds. The CYP1A1 is inductible by the HPA and others compounds like dioxine. This inductibility is itself variable and largely dependent on the receptor Ah (AhR). The AhR is partially responsible for a polymorphic expression of the CYP1A1 and thus could be an important factor in carcinogenicity. We investigated the genetic polymorphisms of the AhR gene in a case-control study of lung cancer. Two new polymorphisms were found, none of them were found to play a key role. . .
RUGGIERI, SOPHIE. "Traitement des cancers du poumon non anaplasiques, non resecables, non metastatiques : a propos de 505 cas". Angers, 1989. http://www.theses.fr/1989ANGE1084.
Testo completoTLEMSANI, LARBI. "Prise en charge du cancer du poumon au centre hospitalier general de cahors de 1989 a 1992". Toulouse 3, 1993. http://www.theses.fr/1993TOU31084.
Testo completoLibri sul tema "Cancer de poumon"
Trédaniel, Jean. Le cancer du poumon. Paris: Masson, 2004.
Cerca il testo completoLaboratoire de lutte contre la maladie (Canada). Bureau du cancer. Le cancer du poumon au Canada. Ottawa, Ont: Santé Canada, 1998.
Cerca il testo completoJ'ai le cancer, et alors? Lyon: Chronique sociale, 2012.
Cerca il testo completoGiovanni, Motta, e Agrigento International Conference on Imaging and Therapy of Lung Cancer. (1st : 1988), a cura di. Lung cancer: Advanced concepts and present status. Genoa: Grafica, L.P., 1989.
Cerca il testo completoM, Lukeman John, e Ordóñz Nelson G, a cura di. Tumors of the lung. Philadelphia: W.B. Saunders, 1991.
Cerca il testo completoLemonde, Manon. Qualité de vie de personnes atteintes de cancer du poumon avancé. Montréal, Qué: Université de Montréal, 1999.
Cerca il testo completo1966-, Sandron Emmanuèle, a cura di. La fille aux neuf perruques: Témoignage. [Paris]: Presses de la Cité, 2009.
Cerca il testo completoMayer, Carole R. Les directives avancées à l'usage des patients atteints du cancer du poumon. Sudbury, Ont: École de Service Social, Université Laurentienne, 1996.
Cerca il testo completoStatistique Canada. Direction des études analytiques. Utilisation de POHEM pour l'estimation des coûts médicaux directs associés à la pratique actuelle du traitement du cancer du poumon ainsi que pour l'évaluation économique de nouveaux traitements. Ottawa, Ont: Statistique Canada, 1997.
Cerca il testo completoNATO Advanced Research Workshop on Mechanisms in Fibre Carcinogenesis (1990 Albuquerque, N.M.). Mechanisms in fibre carcinogenesis. New York: Plenum Press, 1991.
Cerca il testo completoCapitoli di libri sul tema "Cancer de poumon"
Molinié, F., A. Danzon, G. Hédelin e E. A. Sauleau. "Poumon". In Survie des patients atteints de cancer en France, 185–92. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39310-5_25.
Testo completoLozano, S., e J. Mazières. "Le cancer du poumon du sujet âgé". In Oncogériatrie, 79–84. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0142-1_12.
Testo completoDauchy, S., e C. Lopez. "Prise en charge psychologique du patient atteint de cancer du poumon". In Oncologie thoracique, 367–78. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-287-99041-0_24.
Testo completoSocinski, Mark A. "Cancer du poumon". In Médecine interne de Netter, 609–16. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-70951-7.00078-5.
Testo completo"Cancers du poumon". In Méga Guide STAGES IFSI, 89–97. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74529-4.00022-7.
Testo completoAlexandre, J., A. Balian, L. Bensoussan, A. Chaïb, G. Gridel, K. Kinugawa, F. Lamazou et al. "Cancers du poumon". In Le tout en un révisions IFSI, 82–89. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70633-2.50022-6.
Testo completoALLIO, I., A. M. DEMARTINI, J. J. MENEC, V. CARDE e V. TREGUER-HERROU. "Le dépistage par le Laboratoire d’analyses, de surveillance et d’expertise de la Marine de Brest du radon, un gaz radioactif naturel en Bretagne". In Médecine et Armées Vol. 44 No.4, 309–16. Editions des archives contemporaines, 2016. http://dx.doi.org/10.17184/eac.6820.
Testo completoTaber, Douglass. "Alkaloid Synthesis: Crispine A (Zhou), Cermizine C (Zhang), Tangutorine (Poupon), FR901483 (Kerr), Serratezomine A (Johnston)". In Organic Synthesis. Oxford University Press, 2011. http://dx.doi.org/10.1093/oso/9780199764549.003.0061.
Testo completoAtti di convegni sul tema "Cancer de poumon"
Dias, Andrey Luis de Oliveira Gonçalves, Thaíz da Silva Gome e Leila Cristina Soares Brollo. "Câncer de endométrio associado a radiação pélvica prévia paratratamento de câncer de colo uterino: relato de caso". In 45º Congresso da SGORJ XXIV Trocando Ideias. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/jbg-0368-1416-20211311018.
Testo completoMacedo, Aruan Kawally Coutinho De, Felipe De Andrade Moreira, Fernanda Clara Marinheiro Oliveira e Neidivania Medeiros Da Nobrega. "O DIAGNÓSTICO PRECOCE DA LEUCEMIA MIELOIDE AGUDA". In II Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/hematoclil/10.
Testo completo